Clinical trial Recruiting at 1 site Interventional Ages 18 and up Women only

Nipple reconstruction with cross-linked hyaluronic acid after mastectomy

Official title: Impact of Nipple Reconstruction in Mastectomized Patients Using Cross-Linked Hyaluronic Acid Injection.

Run by Germans Trias i Pujol Hospital · NCT07008339 · Data updated 2026-11-12

This trial will test whether adding a cross-linked hyaluronic acid injection to areola micropigmentation helps women who had a mastectomy achieve better nipple projection, appearance, and satisfaction.

More Breast Neoplasms trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment138 (estimated)
SponsorGermans Trias i Pujol Hospital
Academic / other
Locations1 site (Badalona, Barcelona)
StatusRecruiting
StartedJune 2, 2023
Main results expectedJune 2, 2027
Study endsJuly 2, 2029
Registry record updatedJune 6, 2025
Trial IDNCT07008339 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Women aged 18 or older undergoing their first nipple-areola complex reconstruction with micropigmentation after mastectomy, with no prior neo‑nipple surgery and at least six months since their last breast surgery are ideal candidates.

Probably not a fit

Those with known allergy to hyaluronic acid, poor tolerance to needle injections, recent breast surgery (under six months), or who are not seeking nipple reconstruction are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This sequential explanatory mixed-methods project first runs a randomized controlled trial comparing areola micropigmentation alone versus micropigmentation plus hyaluronic acid (HA) nipple injection in 138 participants over 36 months at Germans Trias i Pujol Hospital. Primary outcomes include psychosocial and sexual well-being, satisfaction with breast and nipple appearance (Spanish BREAST-Q and a custom tool), and objective nipple projection measured with calipers. Phase 2 consists of qualitative interviews with a purposive sample of women who received HA to explore personal experiences and meanings of the intervention. The design combines quantitative outcome measurement with qualitative depth to explain how HA injection may affect aesthetic and quality-of-life outcomes.

Why it matters

Potential benefit: If successful, adding HA injection could improve nipple projection and cosmetic satisfaction and lead to better psychosocial and sexual wellbeing after reconstruction.

How similar studies have gone: Use of HA for nipple projection is relatively novel with limited prior data, so rigorous evidence on psychosocial and aesthetic benefits is currently sparse.

Who can join: the full rules

Show full inclusion / exclusion criteria
* Quantitative Phase
* Inclusion Criteria:

Women over 18 years of age, or with parental or legal guardian consent.

At least one of the following criteria:

Women undergoing their first nipple-areola complex (NAC) reconstruction through micropigmentation and/or:

No previous neo-nipple surgery, either unilaterally or bilaterally.

Surgical reconstruction of the areola.

Surgical reconstruction of the NAC with subsequent retraction of the neo-nipple.

More than 6 months since their last surgery.

\- Exclusion Criteria:

Allergy to hyaluronic acid.

Poor tolerance to needle injections.

Withdrawal Criteria:

Participant's voluntary decision.

Complications associated with the technique (allergy, hematoma, etc.).

Clinical deterioration preventing the woman from continuing in the study.

\- Qualitative Phase

Participant Profile Characteristics: For the qualitative phase, women who have received NAC reconstruction with HA will be invited to participate, following the maximum variation criterion. To ensure the inclusion of participants with diverse characteristics and capture a wide range of perspectives and experiences on the phenomenon under study, women of varying ages, with different breast cancer diagnoses, and histories of various oncological, surgical, and therapeutic treatments will be selected.

Where it's running

  • Hospital Universitario Germans Trias i Pujol
    Badalona, Barcelona, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.